Comprehensive cross cancer analyses reveal mutational signature cancer specificity

  • 0Department of Computer Science, University of South Carolina, Columbia, South Carolina, USA.

|

|

Summary

This summary is machine-generated.

Mutational signatures reveal cancer heterogeneity and etiology. While most are distinct, similarities aid in identifying unknown cancer causes, with skin cancer showing high specificity.

Area Of Science

  • Genomics
  • Cancer Research
  • Bioinformatics

Background

  • Mutational signatures are key to understanding cancer etiology.
  • Analyzing these signatures helps elucidate cancer heterogeneity and specificity.
  • Previous studies highlight their role in cancer research.

Purpose Of The Study

  • To investigate cancer heterogeneity and specificity using mutational signatures.
  • To explore similarities and differences between mutational signature pairs.
  • To assess the potential of mutational signatures in determining unknown cancer etiologies.

Main Methods

  • Collinearity analysis was employed to compare mutational signatures.
  • Machine learning techniques were utilized for pattern recognition and classification.
  • Independent validation was performed to ensure result reliability.

Main Results

  • The majority of mutational signatures are distinct.
  • Similarities were found in mutation patterns and abundance between certain signature pairs.
  • Machine learning confirmed moderate cancer specificity for mutational signatures.
  • Skin cancer exhibited the strongest mutational signature specificity.

Conclusions

  • Mutational signature analysis provides insights into cancer heterogeneity.
  • Observed similarities can aid in identifying the causes of elusive mutational signatures.
  • Mutational signatures demonstrate cancer-specific patterns, particularly in skin cancer.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell 02:21

11.4K

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Combination Therapies and Personalized Medicine 02:50

4.8K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer-Critical Genes II: Tumor Suppressor Genes 01:05

7.3K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer Survival Analysis 01:21

321

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Mismatch Repair 01:20

4.7K

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...